Radiotherapy with paclitaxel/cisplatin vs. fluorouracil/cisplatin for head and neck cancer

Fietkau R, Hecht M, Hofner B, Iro H, Gefeller O, Roedel C, Hautmann M, Koelbl O, Salay A, Ruebe C, Breinl P, Krings W, Gripp S, Wollenberg B, Keerl R, Schreck U, Siekmeyer B, Grabenbauer GG, Balermpas P (2019)


Publication Type: Conference contribution

Publication year: 2019

Journal

Publisher: ELSEVIER IRELAND LTD

City/Town: CLARE

Pages Range: S194-S194

Conference Proceedings Title: RADIOTHERAPY AND ONCOLOGY

Event location: Milan IT

DOI: 10.1016/S0167-8140(19)30807-2

Authors with CRIS profile

Involved external institutions

How to cite

APA:

Fietkau, R., Hecht, M., Hofner, B., Iro, H., Gefeller, O., Roedel, C.,... Balermpas, P. (2019). Radiotherapy with paclitaxel/cisplatin vs. fluorouracil/cisplatin for head and neck cancer. In RADIOTHERAPY AND ONCOLOGY (pp. S194-S194). Milan, IT: CLARE: ELSEVIER IRELAND LTD.

MLA:

Fietkau, Rainer, et al. "Radiotherapy with paclitaxel/cisplatin vs. fluorouracil/cisplatin for head and neck cancer." Proceedings of the 38th Annual Meeting of the European-Society-for-Radiotherapy-and-Oncology (ESTRO), Milan CLARE: ELSEVIER IRELAND LTD, 2019. S194-S194.

BibTeX: Download